Antisoma receives $43M from deal with Roche.(F. Hoffmann-La Roche Ltd....
November 25, 2002
|
Alexion, P&G's Phase II trial reduces mortality.(Alexion Pharmaceutica...
November 25, 2002
|
Medicines Co.'s Angiomax study positive.(Brief Article)
November 25, 2002
|
Coley, GSK expand alliance into oncology.(Coley Pharmaceutical Group, ...
November 25, 2002
|
ProdiGene's transgenic plants cause concern.(government investigates c...
November 25, 2002
|
Avanir reports positive results in Neurodex trial.(Avanir Pharmaceutic...
November 25, 2002
|
Genomics raises $17m in series B round.(Psychiatric Genomics Inc.)(Bri...
November 25, 2002
|
Vasogen to start Phase III trial in heart failure.(ACCLAIM trial)(Brie...
November 25, 2002
|
CV Therapeutics reports Phase III data at AHA.(American Heart Associat...
November 25, 2002
|
Palatin raises $11.5m for LeuTech, PT-141 products.(Palatin Technologi...
November 25, 2002
|
Inflazyme expands deal with Aventis.(Inflazyme Pharmaceuticals Ltd., A...
November 25, 2002
|
Inspire in Phase III trial for allergic rhinitis.(Inspire Pharmaceutic...
November 25, 2002
|
Lundbeck acquiring Synaptic for $121m.(H. Lundbeck A/S, Synaptic Pharm...
November 25, 2002
|
TransForm and Weizmann to develop malaria drugs. (News from the Lab).(...
November 25, 2002
|
Genelabs to enter Phase III trial with Prestara.(Genelabs Technologies...
November 25, 2002
|
Structural Genomix takes project lead.(Brief Article)
November 25, 2002
|
SuperGen receives approval for Mitozytrex.(Brief Article)
November 25, 2002
|
ViroLogic plans cuts while it raises $10m.(Brief Article)
November 25, 2002
|
Hyseq and Variagenics to merge in $56m deal.(Hyseq Pharmaceuticals Inc...
November 18, 2002
|
Oral 'chaperones' aim to replace GD therapeutics. (News From the Lab)....
November 18, 2002
|
Northwest bio plans further cutbacks.(Northwest Biotherapeutics Inc.)(...
November 18, 2002
|
Biotech drug prices affected by new rules.(Centers for Medicare and Me...
November 18, 2002
|
Advanced Viral makes cuts, focuses on Product R.(Advanced Viral Resear...
November 18, 2002
|
SangStat, THP enter $45m deal.(SangStat Medical Corp. and Therapeutic ...
November 18, 2002
|
Endo, Durect collaborate on pain system.(Endo Pharmaceuticals Holdings...
November 18, 2002
|
Millennium starts Phase III trial of Integrilin.(Millennium Pharmaceut...
November 18, 2002
|
Baxter agrees to acquire Epic for $50m to $100m.(Baxter Healthcare Cor...
November 18, 2002
|
Incyte buys Maxia, plans reductions.(Incyte Genomics Inc. acquires Max...
November 18, 2002
|
Neurogen drug fails in Phase II Alzheimer's trial.(securities fell 23 ...
November 18, 2002
|
Ligand changes Avinza deal with Elan.(Ligand Pharmaceuticals Inc.)(Bri...
November 18, 2002
|
Dynogen raises $13.3m in first round.(Dynogen Pharmaceutical Inc.)(Bri...
November 18, 2002
|
Celgene buying Anthrogenesis for $45m.(pharmaceutical industry)(Brief ...
November 18, 2002
|
Neurocrine's first Phase III insomnia trial positive.(Neurocrine Biosc...
November 18, 2002
|
Arena, Lilly end GPCR deal early.(Arena Pharmaceuticals Inc./Eli Lilly...
November 18, 2002
|
Advisory panel backs Roche's HCV therapy.(Hoffman-La Roche Inc.)
November 18, 2002
|
Scynexis, Roche enter collaboration.(F. Hoffman-La Roche Ltd.)(Brief A...
November 18, 2002
|
ImClone submits Erbitux Phase III protocols.(Brief Article)
November 11, 2002
|
With DN-101 in Phase II/III, Novacea closes Series B.(Brief Article)
November 11, 2002
|
Alexion data point to long-term treatment.(Brief Article)
November 11, 2002
|
FDA tells Biogen to clean up Avonex claims.(Brief Article)
November 11, 2002
|
Gilead presents Hepsera combination data.(chronic hepatitis B)
November 11, 2002
|
Senesco plans $35m chinese crop deal.(Tianjin Academy of Agricultural ...
November 11, 2002
|
CuraGen, Mitsubishi enter schizophrenia deal.
November 11, 2002
|
Geovax prepares for trials of aids vaccine.(Brief Article)
November 11, 2002
|
Elections give GOP power; industry effects varied.(Brief Article)
November 11, 2002
|
Isis gets Isis 14803 rights back from Elan JV.(Brief Article)
November 11, 2002
|
Discovery Labs raises $12.8m privately.(Brief Article)
November 11, 2002
|
Corixa, Genesis get 'expected' Phase II results.(Brief Article)
November 11, 2002
|
CuraGen reduces employees, cuts back.(Brief Article)
November 11, 2002
|
Seattle Genetics updates clinical pipeline.(Brief Article)
November 11, 2002
|
Amgen impacted by new reimbursement plan.
November 11, 2002
|
Ants duel to the death for queens' wafted chemicals. (News from the La...
November 11, 2002
|
Exelixis, GSK enter deal with $134M guarantee.(GlaxoSmithKline)(Brief ...
November 04, 2002
|
Rats' whiskers perform mental arithmetic. (News from the Lab).(sensory...
November 04, 2002
|
MedImmune expects to take FluMist back to panel.(nasal influenza vacci...
November 04, 2002
|
NPS prices $95.8m offering from shelf.(securities)(Brief Article)
November 04, 2002
|
Harvard Bioscience gains Genomics Solutions.(Brief Article)
November 04, 2002
|
Epimmune to test public waters with $96m offer.(Brief Article)
November 04, 2002
|
Dendreon gets OK to resume enrollment.(hormone-resistant prostate canc...
November 04, 2002
|
Peninsula raises $22.1m to fund in-licensing.(Venture capital financin...
November 04, 2002
|
Abbott's Humira continues to impress.(antiarthritic preparations)(Brie...
November 04, 2002
|
Endo's MorphiDex Phase III misses endpoint.(Painkiller is a disappoint...
November 04, 2002
|
Aphton reports positive G17DT Phase III results.(pancreatic cancer)(Br...
November 04, 2002
|
NIH to develop genetic variation map.(National Institutes of Health)(B...
November 04, 2002
|
Metabasis builds on partnership with Sankyo.(Type II diabetes)(Brief A...
November 04, 2002
|
Anacor lands $21.6M contract, new funding.(Brief Article)
November 04, 2002
|
Inspire says INS365 NDA filing not far off.(dry-eye product)(Brief Art...
November 04, 2002
|
Kemia closes potential $16.5M series A.(Brief Article)
November 04, 2002
|
Neurogenetics closes series B round.(Financing)(Brief Article)
November 04, 2002
|
Serono, IVAX align to develop Cladribine.(MS treatment)(Brief Article)
November 04, 2002
|
Zonagen finds merger partner in Lavipharm.(Brief Article)
November 04, 2002
|
SuperGen plans Orathecin NDA.(pancreatic cancer prep)(Brief Article)
November 04, 2002
|
'Embryo' joins ranks of those requiring protection.(human being)(Brief...
November 04, 2002
|
Cerus gets $50m loan pledge from Baxter.(Brief Article)
November 04, 2002
|
